Biologics share of total drug costs in Canada by public drug plan 2020/2021
In fiscal year 2020/2021, the share of biologics of total drug cost in Nova Scotia's public drug plan amounted to 25.6 percent. This statistic depicts the biologic share of total drug costs in selected Canadian public drug plans in FY 2020/2021.
